The method is practical, inexpensive, and can be quickly implemented. Medscape Medical News
No Comments »
Filed under: General Health News
New guidance on how aspirin should be used in both the primary and secondary prevention of coronary heart disease has come from 3 new published studies. Medscape Medical News
No Comments »
Filed under: General Health News
Body weight and fat increase with the use of depot medroxyprogesterone. After discontinuation of the contraceptive, decrease in body weight and fat occurs when nonhormonal contraception is used. Reuters Health Information
No Comments »
Filed under: General Health News
Blacks have approximately a 1-in-100 chance of developing heart failure while still in their 30s or 40s, a far higher rate vs whites; the risk is tied to hypertension, obesity, or renal dysfunction. Medscape Medical News
No Comments »
Filed under: General Health News
A study shows that women who use the injectable contraceptive DMPA (depot medroxyprogesterone acetate) are apt to experience a significant increase in body weight and fat. Reuters Health Information
No Comments »
Filed under: General Health News
Boehringer Ingelheim announced that the last patient has completed treatment in the landmark phase III Randomized Evaluation of Long term Anticoagulant therapy (RE-LY®) study.
No Comments »
Filed under: Pharmacy News
Pfizer Inc and PlaNet Finance announced that they will team up to conduct an in-depth research project on the healthcare needs of the working poor in China. The study will examine the availability and existing sources of medicines, patient purchasing patterns, and the level of access to medical services. The study ultimately aims to help [...]
No Comments »
Filed under: Pharmacy News
Boehringer Ingelheim announced that the last patient has completed treatment in the Phase III Randomized Evaluation of Long term Anticoagulant therapy (RE-LY(R)) study. This study compared the long-term efficacy and safety of the oral direct thrombin inhibitor dabigatran etexilate with the current standard therapy, warfarin (target international normalized ratio, INR, 2-3) for the prevention of [...]
No Comments »
Filed under: Pharmacy News
Santaris Pharma announced that the fourth LNA-based drug has been brought into the clinic. In the USA several patients with cancer have now been treated with the Company’s Survivin inhibitor, which is jointly developed by Santaris Pharma and Enzon Pharmaceuticals. The U.S. Food and Drug Administration (FDA) recently accepted Enzon Pharmaceutical’s Investigational New Drug (IND) [...]
No Comments »
Filed under: Pharmacy News
Forest Laboratories, Inc. (NYSE: FRX) announced that the U.S. Food and Drug Administration (FDA) has approved the Company’s supplemental New Drug Application (sNDA) for Lexapro (escitalopram oxalate) for the acute and maintenance treatment of Major Depressive Disorder (MDD) in adolescents, 12 - 17 years of age. Lexapro is only the second antidepressant to be [...]
No Comments »
Filed under: Pharmacy News
